Inventor · disambiguated record
John Paul Kilburn
Also filed as: KILBURN JOHN P · KILBURN JOHN PAUL
29 granted patents·11 pending applications·58 citations·filing 2005–2022
95Inventor score
Files withH LUNDBECK AS11LUNDBECK & CO AS H8KILBURN JOHN PAUL4HIGH POINT PHARMACEUTICALS LLC3MINDIMMUNE THERAPEUTICS INC3
Top patents by PatentIndex Score
40 records- 0188US9593105B2Cyclic aminesH LUNDBECK AS·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0286US9415055B2Cyclic aminesH LUNDBECK AS·Filed 2015·Granted Aug 16, 2016·4 cites·18 claims
- 0386US9108938B2Cyclic aminesLUNDBECK & CO AS H·Filed 2013·Granted Aug 18, 2015·7 cites·24 claims
- 0486US8053431B2Pharmaceutical use of substituted amidesHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted Nov 8, 2011·9 cites·8 claims
- 0585US8133897B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsRITZEN ANDREAS·Filed 2009·Granted Mar 13, 2012·10 cites·16 claims
- 0684US9102591B2BenzamidesLUNDBECK & CO AS H·Filed 2013·Granted Aug 11, 2015·6 cites·22 claims
- 0782US11358971B2Prodrugs of modulators of the NMDA receptorH LUNDBECK AS·Filed 2020·Granted Jun 14, 2022·1 cites·36 claims
- 0879US8865711B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsRITZÉN ANDREAS·Filed 2012·Granted Oct 21, 2014·2 cites·24 claims
- 0976US9861639B2Cyclic aminesH LUNDBECK AS·Filed 2017·Granted Jan 9, 2018·1 cites·22 claims
- 1076US8153798B2Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitorsKILBURN JOHN PAUL·Filed 2007·Granted Apr 10, 2012·3 cites·4 claims
- 1176US8138342B211β-hydroxysteroid dehydrogenase type 1 active spiro compoundsKILBURN JOHN PAUL·Filed 2005·Granted Mar 20, 2012·3 cites·2 claims
- 1272US9018217B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsLUNDBECK & CO AS H·Filed 2014·Granted Apr 28, 2015·1 cites·29 claims
- 1371US9649308B2Benzamide-containing compounds and their use in the treatment of painH LUNDBECK AS·Filed 2015·Granted May 16, 2017·1 cites·23 claims
- 1471US8841297B2Phenylimidazole derivative as PDE10A enzyme inhibitorRITZÉN ANDREAS·Filed 2010·Granted Sep 23, 2014·3 cites·12 claims
- 1570US8501795B2(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivativesPUESCHL ASK·Filed 2010·Granted Aug 6, 2013·2 cites·25 claims
- 1667US9062060B2Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitorsLUNDBECK & CO AS H·Filed 2014·Granted Jun 23, 2015·0 cites·16 claims
- 1766US2010120743A111Beta-Hydroxysteroid Dehydrogenase Type 1 Active CompoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 1864US2022213117A1Prodrugs of modulators of the nmda receptorH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 1962US8552045B2Tricyclic imidazole compounds as PDE10 inhibitorsKEHLER JAN·Filed 2011·Granted Oct 8, 2013·0 cites·15 claims
- 2062US2008108598A1Pharmaceutical use of substituted amidesNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2160US8796304B2Tricyclic imidazole compounds as PDE10 inhibitorsLUNDBECK & CO AS H·Filed 2013·Granted Aug 5, 2014·0 cites·11 claims
- 2258US10124010B2Cyclic aminesMIND IMMUNE THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·0 cites·20 claims
- 2358US9592230B2Substituted imidazoles as PDE10A inhibitorsH LUNDBECK AS·Filed 2015·Granted Mar 14, 2017·0 cites·10 claims
- 2458US2019307766A1Cyclic aminesMINDIMMUNE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2556US9216986B1Quinoline derivatives as PDE10A enzyme inhibitorsLUNDBECK & CO AS H·Filed 2012·Granted Dec 22, 2015·0 cites·10 claims
- 2656US2006111366A1Pharmaceutical use of substituted amidesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2755US2020054630A1Benzamides-containing compounds and their use in the treatment of depressionMINDIMMUNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2852US11466027B2Modulators of the NMDA receptorH LUNDBECK AS·Filed 2020·Granted Oct 11, 2022·0 cites·19 claims
- 2951US10238654B2Benzamides-containing compounds and their use in the treatment of epilepsyMINDIMMUNE THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·0 cites·18 claims
- 3051US2009264414A1Amide Derivatives and Pharmaceutical Use ThereofHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 3150US8927738B22-arylimidazole derivatives as PDE10A enzyme inhibitorsLUNDBECK & CO AS H·Filed 2013·Granted Jan 6, 2015·0 cites·7 claims
- 3250US8785653B2(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivativesLUNDBECK & CO AS H·Filed 2013·Granted Jul 22, 2014·0 cites·10 claims
- 3346US9801878B2Quinoline derivatives as PDE10A enzyme inhibitorsH LUNDBECK AS·Filed 2015·Granted Oct 31, 2017·0 cites·15 claims
- 3445US9669029B2Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitorsH LUNDBECK AS·Filed 2015·Granted Jun 6, 2017·0 cites·13 claims
- 3544US2009306048A1Pharmaceutical use of substituted piperidine carboxamidesKILBURN JOHN PAUL·Filed 2007·Application pending·0 cites
- 3644US2009124598A1Pharmaceutical use of substituted amidesANDERSEN HENRIK SUNE·Filed 2006·Application pending·0 cites
- 3744US2011312949A1Pharmaceutical use of substituted amidesKILBURN JOHN PAUL·Filed 2011·Application pending·0 cites
- 3843US8501797B2(2-aryl-1H-imidazol-4-yl)-linked heterocycle derivativesPUESCHL ASK·Filed 2010·Granted Aug 6, 2013·0 cites·25 claims
- 3941US9096589B2Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitorsPüschl Ask·Filed 2010·Granted Aug 4, 2015·0 cites·20 claims
- 4039US2018319786A1Inhibitor of the p2x7 receptorH LUNDBECK AS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Paul Kilburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →